Not exact matches
The scientists also tested the therapy on tumors taken from two
patients who had not responded to conventional therapy for their
glioblastoma, a deadly form of brain cancer.
In 2002 scientists showed that cytomegalovirus, or CMV, was active in the brain tumors but not the surrounding healthy tissue of all 27
patients they tested
who had
glioblastoma multiforme.
This has important treatment implications because loss of P53 is associated with a poor prognosis in these
patients, so a PRMT5 inhibitor might be particularly important for these
patients,» says Kaur,
who is specializes in
glioblastoma research and is chief of Ohio State's Dardinger Laboratory of Neurosciences.
A new population - based study has found that
patients with
glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than
patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer.
Researchers studied survival in 1,715
patients with
glioblastoma who died in 2006, 1,924
who died in 2008 and 1,968
who died in 2010.
Patients with recurrent glioblastoma multiforme (GBM) treated with an experimental vaccine made from the patient's own resected tumor tissue showed an improved survival compared with historical patients who received the standard of care alone, according to an analysis of a phase 2 trial of this vaccine that was recently published in the journal Neuro - Oncology and accompanied by an editorial highlighting the importance of th
Patients with recurrent
glioblastoma multiforme (GBM) treated with an experimental vaccine made from the
patient's own resected tumor tissue showed an improved survival compared with historical
patients who received the standard of care alone, according to an analysis of a phase 2 trial of this vaccine that was recently published in the journal Neuro - Oncology and accompanied by an editorial highlighting the importance of th
patients who received the standard of care alone, according to an analysis of a phase 2 trial of this vaccine that was recently published in the journal Neuro - Oncology and accompanied by an editorial highlighting the importance of the trial.
A Randomized Phase 2 Trial of Cediranib and Olaparib Compared to Bevacizumab in
Patients with Recurrent
Glioblastoma who have not received Prior VEGF Therapy